Cronin has worked at Moderna since 2021, when she was brought on to market the biotech company’s COVID-19 vaccine.
There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...
HHS review of a vaccine contract sparks worries about preparedness for a potential bird flu pandemic
the Department of Health and Human Services has confirmed that it is reevaluating a nearly $600 million contract issued to Cambridge, Mass.-based Moderna by the Biomedical Advanced Research and ...
CAMBRIDGE, MA / ACCESS Newswire / February 25, 2025 / Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences: TD Cowen 45 th Annual Health ...
CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted ...
As of 10:02:58 AM EDT. Market Open. mRESVIA ®is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 /Moderna, Inc. (NASDAQ:MRNA) today announced that ...
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Moderna Inc. (MRNA) on Friday reported a loss of $1.12 billion in its fourth quarter. On a per-share basis, the Cambridge, Massachusetts-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback